KMKalhara R. Menikdiwela

Kalhara R. Menikdiwela

*This is an algorithmically generated author record based on publicly available information.

Kalhara R. Menikdiwela has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Maternal Obesity and Its Epigenetic Effects

    by Latha Ramalingam, Nishan Sudheera Kalupahana, Kalhara R. Menikdiwela, Chathura Ratnayake, Naїma Moustaїd-Moussa

  • Open Access

    Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer

    by Kalhara R. Menikdiwela, Chanaka Kahathuduwa, Michelle L. Bolner, Rakhshanda Layeequr Rahman, Naima Moustaid-Moussa

    Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.


  • Open Access

    Dietary pH Enhancement Improves Metabolic Outcomes in Diet-Induced Obese Male and Female Mice: Effects of Beef vs. Casein Proteins

    by Kalhara R. Menikdiwela, João Pedro Tôrres Guimarães, Shane Scoggin, Lauren S. Gollahon, Naima Moustaid-Moussa

    (1) Consumption of diets that are caloric dense but not nutrient dense have been implicated in metabolic diseases, in part through low-grade metabolic acidosis. Mitigation strategies through dietary intervention to alleviate acidosis have not been previously reported. Our objective is to determine the effects of pH enhancement (with ammonia) in high fat diet-induced obese mice that were fed beef or casein as protein sources compared to low fat diet-fed mice. (2) Methods: B6 male and female mice were randomized (n = 10) into eight diets that differ in protein source, pH enhancement of the protein, and fat content, and fed for 13 weeks: low fat (11% fat) casein (LFC), LF casein pH-enhanced (LFCN), LF lean beef (LFB), LFBN, high fat (46%) casein (HFC), HFCN, HF beef (HFB), and HFBN. Body weights and composition, and glucose tolerance tests were conducted along with terminal serum analyses. Three-way ANOVA was performed. (3) Results: A significant effect of dietary fat (LF vs. HF) was observed across all variables in both sexes (final body weight, fat mass, glucose clearance, and serum leptin). Importantly, pH enhancement significantly reduced adiposity (males only) and final body weights (females only) and significantly improved glucose clearance in both sexes. Lastly, clear sex differences were observed across all variables. (4) Conclusions: Our findings demonstrate metabolic benefits of increasing dietary pH using ammonia, while high fat intake per se (not protein source) is the major contributor to metabolic dysfunctions. Additional research is warranted to determine mechanisms underlying the beneficial effects of pH enhancement, and interactions with dietary fat content and proteins.


  • Open Access

    Sex Differences in Early Programming by Maternal High Fat Diet Induced-Obesity and Fish Oil Supplementation in Mice

    by Latha Ramalingam, Kalhara R. Menikdiwela, Stephani Spainhour, Tochi Eboh, Naima Moustaid-Moussa

    Pre-pregnancy obesity is a contributing factor for impairments in offspring metabolic health. Interventional strategies during pregnancy are a potential approach to alleviate and/or prevent obesity and obesity related metabolic alterations in the offspring. Fish oil (FO), rich in omega-3 polyunsaturated fatty acids (n-3 PUFAs) exerts metabolic health benefits. However, the role of FO in early life remains still unknown. Hence, this study objective was to determine the effect of FO supplementation in mice from pre-pregnancy through lactation, and to study the post-natal metabolic health effects in gonadal fat and liver of offspring fed high fat (HF) diet with or without FO. Female C57BL6J mice aged 4–5 weeks were fed a HF (45% fat) diet supplemented with or without FO (30 g/kg of diet) and low fat (LF; 10% fat) pre-pregnancy through lactation. After weaning, offspring (male and female) from HF or FO dams either continued the same diet (HF-HF and FO-FO) or switched to the other diet (HF-FO and FO-HF) for 13 weeks, creating four groups of treatment, and LF-LF was used as a control group. Serum, gonadal fat and liver tissue were collected at termination for metabolic analyses. Offspring of both sexes fed HF with or without fish oil gained (p < 0.05) more weight post weaning, compared to LF-LF-fed mice. All the female offspring groups supplemented with FO had reduced body weight compared to the respective male groups. Further, FO-FO supplementation in both sexes (p < 0.05) improved glucose clearance and insulin sensitivity compared to HF-HF. All FO-FO fed mice had significantly reduced adipocyte size compared to HF-HF group in both male and females. Inflammation, measured by mRNA levels of monocyte chemoattractant protein 1 (Mcp1), was reduced (p < 0.05) with FO supplementation in both sexes in gonadal fat and in the liver. Markers of fatty acid synthesis, fatty acid synthase (Fasn) showed no sex specific differences in gonadal fat and liver of mice supplemented with HF. Female mice had lower liver triglycerides than male counterparts. Supplementation of FO in mice improved metabolic health of offspring by lowering markers of lipid synthesis and inflammation.


  • Effects of high fat diets and supplemental tart cherry and fish oil on obesity and type 2 diabetes in male and female C57BL/6J and TALLYHO/Jng mice

    by Jacaline K. Parkman, Kristiana Sklioutovskaya-Lopez, Kalhara R. Menikdiwela, Logan Freeman, Naima Moustaid-Moussa, Jung Han Kim


  • Open Access

    Role of microRNA 690 in Mediating Angiotensin II Effects on Inflammation and Endoplasmic Reticulum Stress

    by Kalhara R. Menikdiwela, Latha Ramalingam, Mostafa M. Abbas, Halima Bensmail, Shane Scoggin, Nishan S. Kalupahana, Asha Palat, Preethi Gunaratne, Naima Moustaid-Moussa

    Overactivation of the renin–angiotensin system (RAS) during obesity disrupts adipocyte metabolic homeostasis and induces endoplasmic reticulum (ER) stress and inflammation; however, underlying mechanisms are not well known. We propose that overexpression of angiotensinogen (Agt), the precursor protein of RAS in adipose tissue or treatment of adipocytes with Angiotensin II (Ang II), RAS bioactive hormone, alters specific microRNAs (miRNA), that target ER stress and inflammation leading to adipocyte dysfunction. Epididymal white adipose tissue (WAT) from B6 wild type (Wt) and transgenic male mice overexpressing Agt (Agt-Tg) in adipose tissue and adipocytes treated with Ang II were used. Small RNA sequencing and microarray in WAT identified differentially expressed miRNAs and genes, out of which miR-690 and mitogen-activated protein kinase kinase 3 (MAP2K3) were validated as significantly up- and down-regulated, respectively, in Agt-Tg, and in Ang II-treated adipocytes compared to respective controls. Additionally, the direct regulatory role of miR-690 on MAP2K3 was confirmed using mimic, inhibitors and dual-luciferase reporter assay. Downstream protein targets of MAP2K3 which include p38, NF-κB, IL-6 and CHOP were all reduced. These results indicate a critical post-transcriptional role for miR-690 in inflammation and ER stress. In conclusion, miR-690 plays a protective function and could be a useful target to reduce obesity.


  • Open Access

    Role of microRNA 690 in Mediating Angiotensin II Effects on Endoplasmic Reticulum Stress and Inflammation

    by Kalhara R. Menikdiwela, Latha Ramalingam, Mostafa Hamaza, Halima Bensmail, Nishan Sudheera Kalupahana, Shane Scoggin, Asha Palat, Preethi Gunaratne, Naima Moustaid-Moussa

    Obesity is a complex disease of global epidemic proportions. Several endocrine systems contribute to obesity, including the renin angiotensin system (RAS), which is overexpressed in adipose tissue during obesity. Overactivation of RAS induces endoplasmic reticulum (ER) stress and inflammation, both hallmarks of obesity; however, mechanisms underlying these interactions are not well known. MicroRNAs (miRNA) plays a pivotal role in post transcriptionally regulating genes involved in obesity and other disorders. Here we propose that changes in RAS alters miRNAs, which thereby regulate ER stress and obesity associated inflammation. This hypothesis was tested using male wild type C57BL/6 mice (Wt) and transgenic mice (Agt‐Tg) overexpressing angiotensinogen (Agt) in the adipose tissue. Mice were fed a low fat (LF) diet and white adipose tissues (WAT) were used to perform microarray and small RNA Seq. High‐throughput computational analyses of differentially expressed genes and miRNAs led to top candidates, which were subsequently validated in WAT. Moreover, specific gene targets for top miRNA candidates were identified using bioinformatic analyses (KEGG pathways, TargetScan). To further validate these miRNA‐gene targets we treated 3T3‐L1 adipocytes with miRNA mimics and inhibitors and tested mRNA expression of target genes. We also mutated the complementary binding sequences on the 3’UTR for positive target genes and validated them in cell culture by dual‐luciferase reporter assay. Here we present data related to miRNA 690 which was significantly altered by Agt overexpression. 23 and 8 miRNAs were upregulated and down regulated respectively in adipose tissue from Agt‐Tg mice. miR690 was significantly upregulated by 3‐fold in Agt‐Tg mice compared to Wt mice and it was also recognized as a potential regulator of several MAPKs including mitogen‐activated protein kinase kinase 3 (MAP2K3). Interestingly, in contrast to other inflammatory genes such as interleukin 6 (IL6) and several MAPKs which were significantly (p<0.05) upregulated in adipose tissue from Agt‐Tg mice compared to Wt mice, MAP2K3 was significantly down regulated in both Agt‐Tg compared to Wt mice and also in 3T3‐L1 cells treated with angiotensin II (Ang II) vs non treated controls. MiRNA 690 mimic treated adipocytes showed significantly reduced Map2k3 expression compared to control. This was further confirmed by significantly reduced luciferase activity for mir690 mimic. Furthermore, mutation of complementary binding sequence of MAP2K3 was unable to reduce luciferase activity, confirming the direct regulatory role of miRNA 690 on MAP2K3. Lastly, a downstream target of MAP2K3, IL‐6 also showed similar results at protein level confirming the involvement of miRNA 690 in regulating inflammation when RAS is overexpressed. In conclusion, miRNA 690 play a protective function with RAS overactivation and miR690 could be used as a potential target to reduce RAS‐induced obesity and related metabolic diseases. Support or Funding Information: American Heart Association (NMM) Grant In Aid # 13GRNT15690000


  • Open Access

    Maternal and Postnatal Supplementation of Fish Oil Improves Metabolic Health of Mouse Male Offspring

    by Latha Ramalingam, Kalhara R. Menikdiwela, Stephani Clevenger, Tochi Eboh, London Allen, Iurii Koboziev, Shane Scoggin, Al Maqsudur Rashid, Hanna Moussa, Naima Moustaid‐Moussa

    Objective: Over half of American women of childbearing age have either obesity or overweight. Hence, maternal programming through diet is critical for prevention of diseases in the offspring. Clinical trials with fish oil (FO) report various health benefits; however, it remains unclear whether maternal and postnatal consumption of FO protects offspring from adverse effects of consuming a high‐fat (HF) diet.Methods: Female mice were fed HF diets supplemented without (HF) or with FO from 8 weeks before pregnancy through lactation. A low‐fat (LF) diet was included as a control diet. After weaning, male offspring from HF or FO dams were either continued on their respective diet (HF‐HF and FO‐FO) or switched to the other diet (HF‐FO and FO‐HF) and compared with LF. Phenotypic and mechanistic studies were performed.Results: FO‐FO offspring demonstrated significantly higher glucose clearance and insulin sensitivity compared with other pups fed the HF diet (P < 0.05). Furthermore, FO‐FO pups had lower adiposity, inflammation, and fat deposition in the liver, consistent with reduced markers of hepatic lipogenesis and increased hepatic lipid oxidation.Conclusions: Supplementation of FO during pregnancy and early life is more beneficial than treating with FO either during pregnancy or in pups.